Lapatinib Completed Phase 1 Trials for Advanced or Metastatic ErbB2-overexpressing Breast Cancer / Neoplasms, Breast

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs